who is a candidate for glp-1 Weight Loss Programs in Anaheim GLP-1 Drug Pipeline 2026 |

Note that risks vary depending on population, trial length, and gallstone screening methods: *Risks vary depending on population, trial length, and gallstone screening methods

Side effects are different, too

However, much more research is needed in this area before we can draw firm conclusions or incorporate GLP-1 therapy routinely into male fertility care

Research suggests these adverse events may occur in 40 to 85% of people

Moreover, peptide analogues that are unimolecular co-agonists of both GLP-1R and GCGR are currently in clinical development for the treatment of T2D, obesity and non-alcoholic steatohepatitis (NASH) 2,3,5,6,7